On Monday shares of MannKind Corp. (NASDAQ:MNKD) closed at $3.63. Company’s EPS growth for next 5 years is recorded as 26.80%. MannKind Corporation (NASDAQ:MNKD), announced that it will present at the Bank of America Merrill Lynch 2015 Healthcare Conference on Wednesday, May 13, 2015 at 12:00 pm Pacific Time at the Encore at the Wynn Hotel in Las Vegas, Nevada.
Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) in last trading activity decreased -7.14% to close at $34.57. Company weekly performance is 24.26% while its quarterly performance stands at 35.68%. Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) is -8.81% away from its 52 week high. On May 7, Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) provided recent corporate highlights and reported its financial results for the first quarter ended March 31, 2015. For the first quarter ended March 31, 2015, Alder did not record any revenues compared to $4.8 million for the same period in 2014. The change in revenue was due to Bristol Myers Squibb’s termination of its worldwide rights for clazakizumab, which were returned to Alder in December 2014.
On last trading day Shutterstock, Inc. (NYSE:SSTK) decreased -0.16% to close at $64.16. Its volatility for the week is 3.61% while volatility for the month is 3.13%. SSTK’s sales growth for past 5 years was 39.90% and its EPS growth for past 5 years was -4.82%. Shutterstock, Inc. (NYSE:SSTK) monthly performance is -9.46%. Shutterstock (NYSE:SSTK) had its price objective hosited by Deutsche Bank from $71.00 to $72.00 in a report released on Friday. Deutsche Bank currently has a hold rating on the stock.
Zumiez, Inc. (NASDAQ:ZUMZ) has 0.20% insider ownership while its institutional ownership stands at 74.10%. In last trading activity company’s stock closed at $31.34. On May 06, Zumiez, Inc. (NASDAQ:ZUMZ) announced that total net sales for the four-week period ended May 2, 2015 increased 2.4% to $51.8 million, compared to $50.6 million for the four-week period ended May 3, 2014. The Company’s comparable sales decreased 4.0% for the four-week period compared to a comparable sales increase of 8.2% in the year ago period.
On last trading day Theravance Inc. (NASDAQ:THRX) moved up 0.63% to close at $16.10. Its volatility for the week is 5.70% while volatility for the month is 5.58%. THRX’s sales growth for past 5 years was -19.20% and its EPS growth for past 5 years was 13.30%. Theravance Inc. (NASDAQ:THRX) monthly performance is -6.01%. On May 07, Theravance Biopharma, Inc. (NASDAQ:TBPH) reported financial results for the first quarter ending March 31, 2015. Revenue for the first quarter of 2015 was $20.4 million. Net loss for the first quarter of 2015 was $42.5 million, or $1.29 per share. Cash, cash equivalents, and marketable securities, excluding restricted cash, totaled $274.8 million as of March 31, 2015.